Long-Term Risk of Stroke After Transient Global Amnesia in Two Prospective Cohorts.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
09 2019
Historique:
pubmed: 10 7 2019
medline: 13 3 2020
entrez: 10 7 2019
Statut: ppublish

Résumé

Background and Purpose- Transient global amnesia (TGA) is known as a benign syndrome, but recent data from neuroradiological studies support an ischemic cause in some cases, which might suggest an increased susceptibility to cerebrovascular events. We determined the long-term risk of stroke after a first TGA in 2 independent prospective cohorts. Methods- In 2 independent prospective cohorts of patients with TGA (OXVASC [Oxford Vascular Study], population-based; NU (Northern Umbria) cohort, TGA registry), cardiovascular risk factors and long-term outcomes, including stroke and major cardiovascular events, were identified on follow-up. Cardiovascular risk factors were treated according to primary prevention guidelines. In OXVASC, the age-/sex-adjusted risk of stroke during follow-up was compared with that expected from the rate in the underlying study population. Results- Among 525 patients with TGA (425 NU and 100 OXVASC), mean (SD) age was 65.1 (9.5) years and 42.5% male. Hypertension (58.1%), dyslipidemia (40.4%), and smoking (36.4%) were the most frequent cardiovascular risk factors. The risk of stroke was similar in the 2 cohorts, with a pooled annual risk of 0.6% (95% CI, 0.4-0.9) and a 5-year cumulative risk of 2.7% (1.1-4.3). Moreover, the stroke risk in OXVASC cases was no greater than that expected in the underlying study population (adjusted relative risk=0.73; 0.12-4.54; P=0.74). Conclusions- TGA does not carry an increased risk of stroke, at least when cardiovascular risk factors are treated according to primary prevention guidelines.

Identifiants

pubmed: 31284848
doi: 10.1161/STROKEAHA.119.025720
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2555-2557

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : British Heart Foundation
Pays : United Kingdom

Auteurs

Michele Romoli (M)

From the Centre for the Prevention of Stroke and Dementia, Nuffield Department of Clinical Neuroscience, University of Oxford, United Kingdom (M.R., M.A.T., I.M., L.L., P.M.R.).
Neurology Clinic (M.R., P.E., F.T.C., A.L., N.S., P.S., L.P., P.C.), University of Perugia, Italy.

Maria Assuncao Tuna (MA)

From the Centre for the Prevention of Stroke and Dementia, Nuffield Department of Clinical Neuroscience, University of Oxford, United Kingdom (M.R., M.A.T., I.M., L.L., P.M.R.).

Iain McGurgan (I)

From the Centre for the Prevention of Stroke and Dementia, Nuffield Department of Clinical Neuroscience, University of Oxford, United Kingdom (M.R., M.A.T., I.M., L.L., P.M.R.).

Linxin Li (L)

From the Centre for the Prevention of Stroke and Dementia, Nuffield Department of Clinical Neuroscience, University of Oxford, United Kingdom (M.R., M.A.T., I.M., L.L., P.M.R.).

David Giannandrea (D)

Neurology and Stroke Unit, USL Umbria 1, Gubbio and Città di Castello Hospital, Perugia, Italy (D.G., S.R.).

Paolo Eusebi (P)

Neurology Clinic (M.R., P.E., F.T.C., A.L., N.S., P.S., L.P., P.C.), University of Perugia, Italy.

Federica Tordo Caprioli (F)

Neurology Clinic (M.R., P.E., F.T.C., A.L., N.S., P.S., L.P., P.C.), University of Perugia, Italy.

Antonio Lotti (A)

Neurology Clinic (M.R., P.E., F.T.C., A.L., N.S., P.S., L.P., P.C.), University of Perugia, Italy.

Nicola Salvadori (N)

Neurology Clinic (M.R., P.E., F.T.C., A.L., N.S., P.S., L.P., P.C.), University of Perugia, Italy.

Paola Sarchielli (P)

Neurology Clinic (M.R., P.E., F.T.C., A.L., N.S., P.S., L.P., P.C.), University of Perugia, Italy.

Alessio Gili (A)

S. Maria della Misericordia Hospital, and Public Health Department (A.G., F.S.), University of Perugia, Italy.

Maria Giulia Mosconi (MG)

Stroke Unit (M.G.M., M.P.V., M.P.), University of Perugia, Italy.

Michele Pellizzaro Venti (M)

Stroke Unit (M.G.M., M.P.V., M.P.), University of Perugia, Italy.

Fabrizio Stracci (F)

S. Maria della Misericordia Hospital, and Public Health Department (A.G., F.S.), University of Perugia, Italy.

Stefano Ricci (S)

Neurology and Stroke Unit, USL Umbria 1, Gubbio and Città di Castello Hospital, Perugia, Italy (D.G., S.R.).

Maurizio Paciaroni (M)

Stroke Unit (M.G.M., M.P.V., M.P.), University of Perugia, Italy.

Lucilla Parnetti (L)

Neurology Clinic (M.R., P.E., F.T.C., A.L., N.S., P.S., L.P., P.C.), University of Perugia, Italy.

Paolo Calabresi (P)

Neurology Clinic (M.R., P.E., F.T.C., A.L., N.S., P.S., L.P., P.C.), University of Perugia, Italy.
IRCCS, Santa Lucia, Rome, Italy (P.C.).

Peter Malcolm Rothwell (PM)

From the Centre for the Prevention of Stroke and Dementia, Nuffield Department of Clinical Neuroscience, University of Oxford, United Kingdom (M.R., M.A.T., I.M., L.L., P.M.R.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH